Clinical Benefits Studies

Studies by Application

 
 
Staphylococcal Bacteremia and Blood Culture Contamination
U.S. Jensen, J.D. Knudsen
Clinical Consequences of using PNA FISH. Poster # D-1302b. ECCMID 2011.
 
 
 
F.J. Brewster, K.C. Hazen, S.I. Getchell-White
Determination of Optimal PNA FISH Testing Times in a Major Medical Center. Poster. ASM 2010.
 
Xiaohui CH, Nielsen FT, Kurtzhals JAL, Moser C, Boye K, Christensen JJ, Johansen UR, Westh H.
Management of recurrent pacemaker-related bacteraemia with small colony variant Staphylococcus aureus in a haemodialysis patient.  BMJ Case Reports. 20 August 2009.
 
 
Ly T, Gulia J, Pyrgos V, Waga M, Shoham S. 
Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time.  Ther Clin Risk Manag. 2008 Jun;4(3):637-40.
 
Forrest GN, Mehta S, Weekes E, Lincalis DP, Johnson JK, Venezia RA. 
Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures. 
J Antimicrob Chemother. 2006 Jul;58(1):154-8. Epub 2006 Apr 24.


Enterococcal Bacteremia
D.C. Gamage, D.P. Olson, L.H. Stickell, K.R. Matthias, E.C. Tuttle, D.R. Johnson, C. Valentino, D.E. Nix, N.N. Whitfield, D.M Wolk
Significant Decreases in Mortality and Hospital Costs After Laboratory Testing with PNA FISH. Poster # D-1302b. ICAAC 2011.
 
A. Schilling, E. Neuner, J. Sekeres, J.Y. Yeh, N. Shrestha, G. Hall
Impact of Implementation of Enterococcal Peptide Nucleic Acid In Situ Hybridization (PNA FISH) on Antimicrobial Usage. Poster # 1024. IDSA 2010.
 
 
F.J. Brewster, K.C. Hazen, S.I. Getchell-White
Determination of Optimal PNA FISH Testing Times in a Major Medical Center. Poster. ASM 2010.
 
Forrest GN, Roghmann MC, Toombs LS, Johnson JK, Weekes E, Lincalis DP, Venezia RA. 
Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy. Antimicrob Agents Chemother. 2008 Oct;52(10):3558-63. Epub 2008 Jul 28.



Gram-Negative Bacteremia
 



Candidemia
D.C. Gamage, D.P. Olson, L.H. Stickell, K.R. Matthias, E.C. Tuttle, D.R. Johnson, C. Valentino, D.E. Nix, N.N. Whitfield, D.M Wolk
Significant Decreases in Mortality and Hospital Costs After Laboratory Testing with PNA FISH. Poster # D-1302b. ICAAC 2011.
 
 
 
 
Forrest GN, Johnson JK, Venezia RA. 
Sustained Effect of Peptide Nucleic Acid Fluorescent in-situ Hybridization (PNA FISH) on Antimicrobial Utilization and Costs. Poster # D-787. ICAAC 2009.
 
Della-Latta P, Whittier S, Wu F. 
Impact of Rapid Identification of C. albicans and C. glabrata Directly from Blood Cultures using PNA FISH Technology on Selection of Antifungal Therapy. Poster # P-1382. ECCMID 2008.
 
Forrest GN, Mankes K, Jabra-Rizk MA, Weekes E, Johnson JK, Lincalis DP, Venezia RA. 
Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. J Clin Microbiol. 2006 Sep;44(9):3381-3. 
 
Alexander BD, Ashley ED, Reller LB, Reed SD. 
Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures. Diagn Microbiol Infect Dis. 2006 Apr;54(4):277-82. Epub 2006 Feb 8.